Self-management of Anticoagulation Treatment

Una Ørvim Sølvik23 enrolled

Overview

The aim of the study was to compare self-management of anticoagulant treatment with conventional anticoagulant treatment in Norway.

Patients (n=23) on anticoagulant treatment with warfarin participated in a 27 weeks training program where they learned how to analyse International Normalised Ratio (INR) using the point-of-care instrument CoaguChek® XS and dose warfarin. The patients had to display their skills through a test before considered self-managing. They continued to measure INR weekly for 28 weeks. All INR values during the training program and self-control period were collected. In addition, the patients were told to notify if they had any complications during this period. Ten INR values and complications before enrolment was collected from INR cards and/or their general practioner. The participant filled in a quality of life-questioner at enrolment and after 28 weeks of self-management.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Masking

NONE

Enrollment

Conditions

Long-term Oral Anticoagulant Therapy

Interventions

TrainingOTHER

Patients were trained to monitor INR and dose warfarin

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * on life-long oral anticoagulation therapy * Live in Bergen municipality * Judged to be qualified for patient self-management anticoagulation treatment by their GP * Motivated to follow the training program Exclusion Criteria: * Drug abuse * Liver disease

Outcomes

Primary Outcomes

Change in Time in therapeutic range (TTR)

Time frame: From 39 weeks before enrolment until 28 weeks of self management

Secondary Outcomes

Change in number of complications

Time frame: From 39 weeks before enrolment until 28 weeks of self management

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.